Evidence map›Paper›PMID 30985557›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2019

Predictors of Disengagement in Care for Individuals Receiving Pre-exposure Prophylaxis (PrEP).

Jason Zucker, Caroline Carnevale, Paul Richards, Jacek Slowikowski, Alexander Borsa, Felix Gottlieb, Isabella Vakkur, Christel Hyden, Susan Olender, Alwyn Cohall and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Texting Lost-to-follow-up PrEP Patients from a San Francisco Sexual Health Clinic.Prevention science : the official journal of the Society for Prevention Research · 2022
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Jason ZuckerDivisions of Infectious Diseases, Departments of Internal Medicine and Pediatrics, Columbia University Irving Medical Center, New York, NY.
Caroline CarnevaleHIV Prevention Program, New York Presbyterian Hospital's Comprehensive Health Center, New York, NY.
Paul RichardsHIV Prevention Program, New York Presbyterian Hospital's Comprehensive Health Center, New York, NY.
Jacek SlowikowskiComprehensive Health Program (CHP), New York Presbyterian Hospital, New York, NY.
Alexander BorsaHIV Prevention Program, New York Presbyterian Hospital's Comprehensive Health Center, New York, NY.
Felix GottliebFieldston School, New York, NY.
Isabella VakkurBowdoin College, Brunswick, ME.
Christel HydenDepartment of Family and Social Medicine, Albert Einstein College of Medicine, New York, NY.
Susan OlenderDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Medical Center, New York, NY.
Alwyn CohallSociomedical Sciences, Population and Family Health, and Pediatrics, Mailman School of Public Health and Columbia University Medical Center, New York, NY.
Peter GordonDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Medical Center, New York, NY.
Magdalena E SobieszczykDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Medical Center, New York, NY.
Columbia University Irving Medical Center · USNewYork–Presbyterian Hospital · USAlbert Einstein College of Medicine · USBowdoin College · USNew York Hospital Queens · US

Funding

Training in Pediatric Infectious DiseasesT32AI007531 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRINCE, ALICE S, SAIMAN, LISA · 1998 to 2023
$4.0M
NIAID NIH HHS L30 AI133789NIAID NIH HHS T32 AI007531
6 · The paper itself

Abstract

backgroundHIV pre-exposure prophylaxis (PrEP) reduces incident HIV infections, but efficacy depends on adherence and retention, among other factors. Substance use disorders, unmet mental health needs, and demographic factors are associated with nonadherence in HIV-infected patients; we studied whether these affect PrEP retention in care.

methodsTo investigate potential risk factors disengagement in a comprehensive HIV prevention program, we conducted a retrospective cohort analysis of individuals starting tenofovir-emtricitabine between January 1, 2015, and November 30, 2017. The primary outcome was adherence to the initial 3-visit schedule after PrEP initiation.

resultsThe cohort was predominantly African American (23%) and Hispanic (46%). Race, ethnicity, substance use, patient health questionnaire 9 score, insurance, and housing status were not associated with retention at the third follow-up visit. Age <30, PrEP initiation in 2017, PrEP initiation in the sexual health clinic, and PrEP same-day start were associated with lower retention; male gender at birth, transition from post-exposure prophylaxis (PEP) to PrEP, feeling that they could benefit from, or participating in mental health services were associated with increased retention. Overall, retention in HIV preventative care at the first follow-up visit (68%) and third follow-up visit (35%) after PrEP initiation was low.

conclusionClinic services and ancillary services (such as mental health) may facilitate retention in care. In this study, select social and behavioral determinants of health were not found to be linked to retention. Focused investigation of reasons for dropout may elucidate the challenges to maintaining individuals in PrEP care and direct resource allocation to those in greatest need.

Indexed as

AdultAnti-HIV AgentsBlack or African AmericanDrug CombinationsEmtricitabineEthnicityFemaleHispanic or LatinoHIV InfectionsHumansMalePre-Exposure ProphylaxisRetrospective StudiesRisk FactorsSexual BehaviorSurveys and QuestionnairesAnti-HIV AgentsDrug CombinationsEmtricitabineTenofovir

Identifiers

PMID30985557
PMCPMC6594905
OpenAlexW2939213073

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.